DDInter1905 DDInter808
Urokinase is an endogenous peptide that is cleaved in the presence of plasmin between lysine 158 and isoleucine 159 to yield active urokinase. Urokinase remains connected between these 2 chains by a sulfhydryl bond. Urokinase was granted FDA approval on 16 January 1978.
Garlic allergenic extract is used in allergenic testing.
Urokinase {u} may cause a minor interaction that can limit clinical effects when taken with {v} Capsicum
Urokinase {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Ticagrelor
Urokinase {u} may lead to a major life threatening interaction when taken with {v} Dasatinib
Urokinase {u} may lead to a major life threatening interaction when taken with {v} Bivalirudin
Urokinase may cause a minor interaction that can limit clinical effects when taken with Capsicum
Urokinase may cause a moderate interaction that could exacerbate diseases when taken with Ticagrelor
Urokinase may lead to a major life threatening interaction when taken with Dasatinib
Urokinase may lead to a major life threatening interaction when taken with Bivalirudin